Construction of plasmids Plasmids and oligonucleotides are listed in Tables S1 and S2, respectively. Approximate positions of selected restriction sites used to construct the plasmids are shown in Figure S1 .
pBSKB-lacIPN. The plasmid pUA-lacIM(M-6ZA) was created by transferring the Acc65I-ApaLI fragment from pAC-lacIM(M-6ZA) into pUA-lacI Q M(M-6ZA).
The plasmids pUA-lacIN(N-6ZA) and pUA-lacIP(P-6ZA) were created by inserting the 18 nt binding site of the 6ZA zinc finger protein into the NheI site of pUA-lacIN or into the PvuI site of pUA-lacIP using the AK405-AK406 and AK407-AK408 oligoduplexes, respectively (Table S2 ). The 6ZB binding site (AK409-AK410 and AK411-AK412) was inserted into the NheI and the PvuI site to obtain pUA-lacIN(N-6ZB) and pUA-lacIP(P-6ZB).
The original CAATTC sequence located in the 5'-untranslated region of the lacI gene was converted into an EcoRI recognition site by the QuickChange site-directed mutagenesis method using pUA-lacI or some of its previously created variants as template and two complementary primers (AK510 and AK511) as mutagenic primers. The primers contained an EcoRI site (Table S2 ). The reaction mixture contained 200 ng of the DNA template, 125 ng of each primer, 2 mM dNTP, 10 µl 5x GC Phusion buffer and 1 µl of Phusion DNA polymerase in 50 µl. The PCR reaction was started with 5 min incubation at 98°C followed by 18 cycles of denaturation at 98°C for 30 sec, annealing at 52°C for 30 sec and elongation at 72°C for 150 sec. The last elongation step lasted for 8 min at 72°C. After the reaction, the samples were digested with DpnI to eliminate the Dam-methylated parental strands. The DpnI-digested samples were transformed into E. coli DH10B cells. The following variants were created by this technique: pUA-lacIE, pUA-lacINE, pUA-lacIPE, pUA-lacIPNE and pUA-lacINE(N-6ZB). The letters in subscript indicate the cloning site(s) created in the lacI promoter region: N, NheI, P, PvuI, E, EcoRI.
The pUA-lacI plasmid variants contained an EcoRI site downstream of the lacI gene. To have a unique EcoRI cloning site in the lacI promoter region, the downstream EcoRI site was eliminated by digesting the plasmid with EcoRI and BsaI, and filling-in the ends with Klenow DNA polymerase to obtain pdUA-lacI. The deletion removed the gene of the green fluorescent protein present in pUA66 but left the rrnB T1 terminator intact. The pdUA-based plasmids carrying the lacI promoter variants with the different engineered cloning sites were constructed by replacing the XhoI-Psp1406I fragment ( Figure S1 ) of pdUA-lacI carrying the wild-type promoter region with the corresponding XhoI-Psp1406I fragments taken from the pUA-lacI variants. The 6ZA and 6ZB zinc finger's binding sites were inserted into the EcoRI site by cloning the AK276-277 or the AK278-279 oligoduplex into the EcoRI site. The plasmid pdUA-lacIN(N-λOR) was constructed by inserting the AK330-331 oligoduplex (Table S2 ) into the NheI site of pdUA-lacIN. The pdUA-based plasmids created are listed in Table S1 .
The GFP-reporter plasmids pUA-dlacI and pUA-dlacIN were created from pUA-lacI and pUA-lacIN, respectively by deleting the Psp1406I-BamHI fragment carrying the body of the lacI gene. The deletion fused the lacI and lacIN promoters to the gene of the green fluorescent protein present in the vector pUA66.
The plasmids pB6ZA and pB6ZB contain the genes of the 6ZA and 6ZB zinc finger proteins, respectively cloned in pBAD24.
The pdCas9-based plasmids pdCas9-AK376, pdCas9-AK385, pdCas9-AK458 pdCas9-AK516, pdCas9-AK518 and pdCas9-AK520 were constructed by cloning the double-stranded oligonucleotides AK376-377, AK385-386, AK458-459, AK516-517, AK518-519 and AK520-521 between the two BsaI acceptor sites of pdCas9. The numbers in the names of the plasmids indicate the oligonucleotide corresponding to the top strand of the targeted sequence (Figure 2 , Tables S1 and S2).
The plasmid pcI857 constitutively expressing the temperature-sensitive cI857 mutant of the lambda phage repressor was created by digesting the plasmid pORTMAGE-2 (4) with Bsp119I and XagI, filling-in the ends with Klenow DNA polymerase and circularizing the large fragment.
To place the lacIN gene with the 6ZA binding site and the gene encoding the 6ZA protein on the same plasmid, first the 6ZA gene was cloned between the EcoRI and SalI sites of the plasmid vector pSEVA3513. In the plasmid obtained (pS6ZA) the 6ZA gene is transcribed from the constitutive EM7 promoter (5) . A DNA fragment encompassing the EM7 promoter, the 6ZA coding sequence and the transcriptional terminator located downstream of the 6ZA gene was PCR-amplified from pS6ZA using the oligonucleotides AK582 and AK583 as primers. The synthesized fragment was cloned into the AfeI site of pdUA-lacIN-(N-6ZA) to obtain pdUA-lacIN(N-6ZA)-(EM7-6ZA).
Nucleotide sequences of the plasmids are available upon request.
Determination of β-galactosidase activity
β-galactosidase activity in permeabilized E. coli cells was determined by the original (6) or by a simplified version (7) of the Miller protocol. In the classical method (6) the bacteria were grown in 5 ml LB liquid medium supplemented with the appropriate antibiotics. To induce expression of the tested protein, 0.1% arabinose was added at OD600 ~0.3 to the culture, and growth was continued at 30 o C for 8 h. At the end of culturing OD600 was recorded and the cells were sedimented by centrifugation (13,000 rpm for 5 min). The pelleted cells were suspended in 1 ml Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50mM βmercaptoethanol), then permeabilized by adding 60 μl chloroform and 30 μl 0.1% sodium dodecyl sulfate (SDS) to the suspension. After brief vortexing 0.1 ml of the cell suspension was added to 0.9 ml Z buffer and incubated at 30 o C for 5 min. Determination of β-galactosidase activity was started by adding 0.2 ml of 4 mg/ml O-Nitrophenyl-β-D-galactopyranoside (ONPG). After 30 min, the reaction was stopped by adding 0.5 ml of 1M Na2CO3. The optical densities at 420 and 550 nm were recorded. β-galactosidase activity was calulated using the equation 1000 x (A420 -1,75 x A550) / (reaction time x volume x A600) (6) . The simplified method (7) was used with modifications essentially as described at https://openwetware.org/wiki/Beta-Galactosidase_Assay_(A_better_Miller).
Typically, overnight cultures were used. After recording OD600 as a measure of cell density, 20 µl of the culture was added to 80 µl permeabilization solution containing 100 mM Na2HPO4, 20 mM KCl, 2 mM MgSO4, 0.8 mg/ml hexadecyltrimethylammonium bromide (CTAB), 0.4 mg/ml sodium deoxycholate and 5.4 µl/ml β-mercaptoethanol. The samples were placed to 30°C for 20-30 minutes, then β-galactosidase reaction was started by adding 600 µl substrate solution (1 mg/ml ONPG, 60 mM Na2HPO4, 40 mM NaH2PO4 and 2.7 µl/ml β-mercaptoethanol). After 60 min at 30°C the reaction was stopped by adding 700 µl of 1M Na2CO3. The samples were cleared by centrifugation at 13,000 rpm for 5 min, then the concentration of the produced onitrophenol was determined by measuring absorbance at 420 nm. Because the reaction mixture was cleared by centrifugation, a simplified equation was used to calculate β-galactosidase activity: 1000 x A420/A600 x volume x reaction time = 60 min.
In the microplate version of the assay cells were grown in 96-well-microplates with medium shaking in Synergy™ HT or Synergy™ 2 Multi-Mode Microplate Readers (BioTek) at 30°C. After overnight incubation OD600 characterizing cell density was recorded, then 5 µl aliquots of the cultures were transferred into wells of a new microplate. Cells were permeabilized by adding 45 µl of CTAB-containing permeabilization solution (see above). Determination of β-galactosidase activity was started with the addition of 300 µl substrate solution (see above). The optical density was recorded at 420 nm and 550 nm for 1 hour with 10 minutes intervals. Miller units were calculated as described in the original method: 1000 x (A420 -1.75 x A550) / (A600 x volume x reaction time).
For detecting β-galactosidase activity in bacterial colonies, E. coli ER1821ΔlacI cells containing the plasmids to be tested were grown to a cell density of OD600 ~ 0.2, then 0.1 ml of the 10 4 -or 10 5 -fold diluted cultures were spread on the surface of agar plates contaning 10 g/l tryptone, 2.5 g/l yeast extract, 10 g/l sodium chloride, 15 g/l agar, the appropriate antibiotics and 40 µg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal). The LB plates used in these experiments contained only half of the standard concentration of yeast extract. In our hands LB agar plates with reduced concentration of yeast extract allowed better discrimination between Lac+ and Lac-colonies than the standard LB plates. The plates were incubated overnight at 37 o C.
Estimation of promoter activity using GFP reporter plasmids E. coli ER1821ΔlacI harboring either pUA-dlacI or pUA-dlacIN were grown overnight in M9 medium (8) supplemented with 0.2% casamino acids, 0.4% glucose and 25µg/ml kanamycin in 96-well microtiter plates at 37°C with medium shaking. Next day the cultures were 1:100 diluted into fresh supplemented M9 medium in a new sterile 96-well plate. Fluorescence and absorbance were measured for 22 hours with 5 minutes intervals in a Synergy™ 2 Multi-Mode Microplate Reader (Bio-Tek) using 500/27nm excitation filter and 528/20 emission filter. The cell density was recorded at 600 nm. Data on Figure S4 represent the average of eight biological repeats. Cultures of E. coli ER1821ΔlacI harboring pdUA-lacI, which did not contain the gfp gene, was used as negative control. The GFP data points were divided by the corresponding OD600 values. Values of the negative control were subtracted from the GFP data points of the two reporter plasmids. OD and GFP curves were time-shifted, so that the cell densities reach 20% of their maximal OD at the same time point. ( Figure S4 ).
Construction of the assay system and pilot experiments
In the experiments described in this section β-galactosidase activity was determined by the original version of the Miller method (6), see above.
The first version of the pLacI plasmids (pOK-lacI Q M) was prepared by cloning the lacI Q gene into the pOK12 plasmid vector, and by creating a MunI cloning site between the -10 element and the GTG start codon of the lacI gene ( Figure 2 and Table S1 ). When pOK-lacI Q M was introduced into E. coli ER1821ΔlacI, β-galactosidase synthesis was not reproducibly repressed, it varied from experiment to experiment. We thought that the irreproducibility of repression was caused by the lac operator on pOK12, which could titrate out the Lac repressor. To circumvent this potential problem, we transferred the lacI Q M gene from pOK-lacI Q M into pACYC184, which has the same replication origin as pOK12 (p15A) but lacks the lac operator (9) . ER1821ΔlacI cells harboring pAC-lacI Q M had steadily low β-galactosidase levels suggesting that our assumption was probably correct, the lack of stable repression was caused by the presence of the lac operator on pOK-lacI Q M.
The 6ZA and 6ZB recognition sites were inserted into pAC We assumed that 6ZA and 6ZB binding was not detected because the multiple plasmidborne copies of the lacI Q gene and the elevated transcription rate characterizing the lacI Q promoter (10-12) resulted in Lac repressor concentrations, which were too high for achieving even partial induction of the lac operon. We tried to lower the concentration of the Lac repressor by replacing the pACYC184 vector with the low copy number plasmid vector pUA66 and the strong lacI Q promoter with the weaker (10) wild-type lacI promoter. The pUA66-based plasmids [pUA-lacIM(M-6ZA) and pUA-lacIM(M-6ZB)] contain the wild-type lacI gene with the 6ZA or the 6ZB recognition sites inserted into the engineered MunI site of the plasmids. Both plasmids repressed β-galactosidase synthesis in ER1821ΔlacI, but introduction of pB6ZA or pB6ZB into ER1821ΔlacI harboring pUA-lacIM(M-6ZA) and pUA-lacIM(M-6ZB), respectively, and growing the cultures in the presence of arabinose did not lead to an increase of β-galactosidase activity (for pUA-lacIM(M-6ZA), see Figure S2 A).
It seemed unlikely that the 6ZA and 6ZB zinc finger proteins whose binding to their recognition sequences was demonstrated in vitro (13) , would not bind to the same sites in E. coli. The MunI site is located between the promoter and the translational initiation site, making interference with lacI transcription reliant on roadblocking by the bound zinc finger protein. It seemed possible that the failure to detect binding was that under the conditions of the assay roadblocking, which is known to be dependent on several factors (14) (15), was not efficient enough to block transcription. We hypothesized that a protein might more efficiently interfere with transcription by competing with binding of RNA polymerase to the promoter than by the obstructing the transcribing enzyme. To establish a system for monitoring binding competition, the lacI promoter was scanned for sequences, which could be converted, by single nucleotide changes, into unique restriction sites in the plasmid. A PvuI site located a few bp upstream of the -35 conserved motif and an NheI site partially overlapping the -10 conserved motif were created. Creation of the NheI site introduced an A to C change in the -10 box (Figure 2) . A third variant (lacINP) contained the NheI as well as the PvuI site. The pUA66-based plasmids carrying these lacI variants and the 6ZA recognition site inserted in the PvuI or in the NheI acceptor site were named pUA-lacIP(P-6ZA), pUA-lacIN(N-6ZA), pUA-lacIPN(P-6ZA) and pUA-lacIPN(N-6ZA) ( Table S1 ). All four plasmids repressed β-galactosidase production in E. coli ER1821ΔlacI (Figure S2 B -E), but increase of β-galactosidase synthesis upon 6ZA production occurred only in the cases when the 6ZA target sequence was in the NheI site ( Figure S2 C and E), it was not observed when the target sequence was in the PvuI site ( Figure S2 B and D) . These results suggested that the NheI site overlapping the -10 element could be a usable acceptor site for target sequences. Here it must be noted that when, in similar experiments, binding of another zinc finger protein (6ZB) to its cognate site was tested [pUA-lacIN(N-6ZB) or pUA-lacIPN(N-6ZB) plus pB6ZB], no increase of β-galactosidase activity was observed (not shown).
To test the assay system with a non-zinc finger DNA binding protein, E. coli ER1821ΔlacI was co-transformed with variants of the pUA-lacI plasmids and a plasmid expressing dCas9 plus one of three guide RNAs. The guide RNA encoded by pdCas9-AK385 overlapped the -35 element (from positions -41 to -22), whereas the guide RNAs encoded by pdCas9-AK376 and pdCas9-AK458 corresponded to the first 20 transcibed nucleotides ( Figure  2 , AK385, AK376 and AK458). Targeting dCas9 to the sequence between positions -41 and -22 (AK385) did not induce β-galactosidase production ( Figure S3 , A -E), whereas targeting to the sequence +1 to + 20 (AK376, Figure 2 ) led to a significant increase of β-galactosidase activity, but only with lacI promoter variants carrying the NheI site ( Figure S3 , I and J). Because in the experiments with dCas9 no foreign sequence was in the NheI site, we concluded that the increase of β-galactosidase activity observed with the lacIN and lacIPN variants ( Figure S3 , I and J) was due to the A to C mutation associated with the creation of the NheI site in the lacI promoter ( Figure 2) . A possible explanation was that the mutation weakened the lacI promoter, which in turn lowered the Lac repressor concentration in the cell to a range, where the competing effect of the tested proteins became detectable. A comparison of the promoters using fusions to the green fluorescent protein (gfp) reporter gene showed that the lacIN promoter was indeed weaker than the wild-type lacI promoter ( Figure S4 ).
Statistical analysis of selected data in Figures 3 and 4
Data were analyzed by one-way ANOVA test folowed by Tukey's Multiple Comparison Test using GraphPad Prism software.
6ZA (test tube) Data: Figure 3A Figure 2 ). The presence of PvuI, NheI or EcoRI acceptor sites is indicated by the letters P, N and E in lower index. The plasmids pdCas9-AK516, pdCas9-AK518 and pdCas9-AK520 express the dCas9 protein and a guide RNA determining the dCas9 binding site (AK516, AK518 and AK520, Figure 2 ). 
